Mesh : Humans COVID-19 / prevention & control economics epidemiology United States / epidemiology Cost-Benefit Analysis COVID-19 Vaccines / economics administration & dosage United States Dept. of Health and Human Services Health Promotion / economics methods SARS-CoV-2 Vaccination / economics Hospitalization / economics statistics & numerical data

来  源:   DOI:10.1016/j.amepre.2024.03.018   PDF(Pubmed)

Abstract:
This study estimated the benefits and costs of the U.S. Department of Health and Human Services\' We Can Do This COVID-19 public education campaign (the Campaign) and associated vaccination-related impacts.
Weekly media market and national Campaign expenditures were used to estimate weekly first-dose vaccinations that would not have occurred absent the Campaign, weekly Campaign-attributed complete vaccinations, and corresponding COVID-19 cases, hospitalizations, and deaths averted. Benefits were valued using estimated morbidity and mortality reductions and associated values of a statistical life and a statistical case. Costs were estimated using Campaign paid media expenditures and corresponding vaccination costs. The net Campaign and vaccination benefit and return on investment were calculated. Analyses were conducted from 2022 to 2024.
Between April 2021 and March 2022, an estimated 55.9 million doses of COVID-19 vaccines would not have been administered absent the Campaign. Campaign-attributed vaccinations resulted in 2,576,133 fewer mild COVID-19 cases, 243,979 fewer nonfatal COVID-19 hospitalizations, and 51,675 lives saved from COVID-19. The total Campaign benefit was $740.2 billion, and Campaign and vaccination costs totaled $8.3 billion, with net benefits of approximately $732.0 billion. For every $1 spent, the Campaign and corresponding vaccination costs resulted in benefits of approximately $89.54.
The We Can Do This COVID-19 public education campaign saved more than 50,000 lives and prevented hundreds of thousands of hospitalizations and millions of COVID-19 cases, representing hundreds of billions of dollars in benefits in less than one year. Findings suggest that public education campaigns are a cost-effective approach to reducing COVID-19 morbidity and mortality.
摘要:
背景:这项研究估计了美国卫生与人类服务部的收益和成本,“我们可以做这项COVID-19公共教育运动(运动)和相关的疫苗接种相关影响。
方法:使用每周媒体市场和国家运动支出来估计每周第一剂疫苗接种,如果没有运动,每周由Campaign指定的完整疫苗接种,以及相应的COVID-19病例,住院治疗,避免了死亡。使用估计的发病率和死亡率降低以及统计寿命和统计病例的相关值来评估益处。使用Campaign支付的媒体支出和相应的疫苗接种费用估算了成本。计算了净运动和疫苗接种效益和投资回报率。从2022年到2024年进行了分析。
结果:在2021年4月至2022年3月之间,如果没有这项运动,估计将不会使用5590万剂COVID-19疫苗。运动疫苗接种导致轻度COVID-19病例减少2,576,133例,非致命性COVID-19住院人数减少243,979人,从COVID-19中拯救了51,675条生命。竞选总收益为7402亿美元,运动和疫苗接种费用总计83亿美元,净收益约为7320亿美元。每花1美元,这项运动和相应的疫苗接种费用带来了约89.54美元的收益.
结论:我们可以做到的这项COVID-19公共教育活动挽救了5万多人的生命,防止了数十万人住院和数百万例COVID-19病例,在不到一年的时间里代表了数千亿美元的福利。研究结果表明,公共教育运动是降低COVID-19发病率和死亡率的一种具有成本效益的方法。
公众号